Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. tirzepatide supplier near you. for tirzepatide dosage This strategic takeover signals Bachem's ambitious plans to dominate the growing market for peptide-based medication